Mitochondria come together to kill cancer cells

September 12, 2018, Hokkaido University
Dispersed mitochondria (green, left) aggregated when Arf6 was disrupted (right) in a cancer cell, leading to excessive production of reactive oxygen species. Credit: Onodera Y., et al., Nature Communications, July 11, 2018

Targeting a pathway that controls the movement of mitochondria, the powerhouses of all cells, could reduce cancer invasiveness and resistance to radiotherapy.

A team of Hokkaido University scientists studied the molecules involved in mitochondrial movements within highly invasive breast . They identified a pathway that ultimately leads to the dispersion of these energy-generating organelles towards the cells' periphery, increasing invasiveness.

When this pathway was blocked, mitochondria aggregated within the cell's center, where they started overproducing and leaking (ROS)—unstable oxygen-containing molecules. ROS is known to enhance cancer invasiveness but in excessive amounts, it can lead to cancer cell death.

Mitochondria are known to relocate within the cellular cytoplasm when different types of cells move. For example, they gather at the tail end of moving toward a foreign invader, and at the leading edge of invading cancer cells. An adhesion protein on the cell surface, called integrin, is also known to promote cancer invasiveness. The mechanisms lying behind these movements, however, are still not fully understood.

Some treatments, including ionizing radiation, increase the production of ROS within cancer cells, contributing to their anti-cancer effects. But some cancer cells develop a tolerance to ROS that allows them to handle more of them. The researchers wanted to investigate mitochondrial movements within cancer cells, and the relation between those movements, integrin, and ROS, all of which are involved in cancer invasion.

In the study published in Nature Communications, the team tagged a variety of molecules inside invasive with fluorescent compounds to follow the mitochondrial movements and ROS production. They then blocked key molecules that are involved in invasiveness.

They found that a molecular pathway which facilitates the recycling of integrin within the cell, called Arf6-AMP1-PRKD2, also facilitates the localization of mitochondria. Integrin accumulation leads to the formation of an adhesion complex at the cell membrane, which ultimately induces trafficking of mitochondria to the cell periphery. Disrupting this pathway led to the aggregation of mitochondria near the cell centre, reducing cancer cell invasiveness. During the experiment, the team also directly modified the mitochondrial distribution, finding that mitochondrial aggregation by itself leads to the production of excessive ROS, resulting in cancer cell death.

These findings suggest that the favouring mitochondrial dispersal makes cancer cells more resistant to treatments that try to kill the cell by increasing reactive oxygen species production.

According to the researchers, their findings indicate "a novel molecular link between cell movements and dynamics, which appears to be crucial for both the invasive activity and tolerance to reactive oxygen species of highly invasive cancers. Our findings may also lead to novel strategies to improve the efficacy of reactive oxygen species-mediated cancer therapies, such as ionizing radiation."

Explore further: How targeting metabolism can defeat cancer stem cells

More information: Yasuhito Onodera et al. Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe, Nature Communications (2018). DOI: 10.1038/s41467-018-05087-7

Related Stories

How targeting metabolism can defeat cancer stem cells

July 3, 2018
Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment.

Study unveils novel link between cell polarity and cancer-associated inflammation

March 20, 2017
A new study led by University of Kentucky Markey Cancer researchers and published in the Journal of Cell Science establishes a novel link between cell polarity and cancer-associated inflammation.

Tests starve cancer cells while leaving normal cells unaffected

March 21, 2018
Scientists seeking to make chemotherapies which are less harmful to cancer patients have reported "highly promising" results from a synthetic molecule called TPP.

Recommended for you

Use genetic data to predict the best time of day to give radiotherapy to breast cancer patients, say researchers

November 19, 2018
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy ...

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

New dual-action cancer-killing virus

November 19, 2018
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.